Recent publications in medical microbiology and immunology: a retrospective (Q37849932)

24 August 2017

title

Recent publications in medical microbiology and immunology: a retrospective (English)

1 reference

24 August 2017

0 references

H W Doerr

1

1 reference

24 August 2017

J Cinatl

series ordinal

2

1 reference

24 August 2017

publication date

29 October 2011

1 reference

Medical Microbiology and Immunology

24 August 2017

published in

1 reference

24 August 2017

volume

201

1 reference

24 August 2017

issue

1

1 reference

24 August 2017

page(s)

1-5

1 reference

The threat of avian influenza A (H5N1). Part I: Epidemiologic concerns and virulence determinants.

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

The threat of avian influenza A (H5N1). Part IV: Development of vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

Will the next human influenza pandemic be caused by the virus of the avian flu A/H5N1? Arguments pro and counter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

Of chickens and men: avian influenza in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

Hand, foot and mouth disease: seroprevalence of Coxsackie A16 and Enterovirus 71 in Germany.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

Novel swine-origin influenza A virus in humans: another pandemic knocking at the door.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

An influenza A H1N1 virus revival - pandemic H1N1/09 virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

Current knowledge on PB1-F2 of influenza A viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

Comparison of pro-inflammatory cytokine expression and cellular signal transduction in human macrophages infected with different influenza A viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

Possible hidden hazards of mass vaccination against new influenza A/H1N1: have the cardiovascular risks been adequately weighed?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

Immune response after two doses of the novel split virion, adjuvanted pandemic H1N1 influenza A vaccine in HIV-1-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

Determination of serum antibodies against swine-origin influenza A virus H1N1/09 by immunofluorescence, haemagglutination inhibition, and by neutralization tests: how is the prevalence rate of protecting antibodies in humans?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

Limited prevalence of influenza A/H1N1v antibodies: footprints of the pandemic of 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

Laboratory diagnosis of influenza--virology or serology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

Seroprevalence of influenza A and B in German infants and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

Investigation of the influence of EPs® 7630, a herbal drug preparation from Pelargonium sidoides, on replication of a broad panel of respiratory viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

Glycyrrhizin exerts antioxidative effects in H5N1 influenza A virus-infected cells and inhibits virus replication and pro-inflammatory gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

Glycyrrhizin inhibits highly pathogenic H5N1 influenza A virus-induced pro-inflammatory cytokine and chemokine expression in human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

Therapy of experimental influenza virus infection with pyrrolidine dithiocarbamate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

Tumor cells infected with oncolytic influenza A virus prime natural killer cells for lysis of resistant tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

Antiviral therapy of chronic hepatitis C in patients with advanced liver disease and after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

Immune complexed (IC) hepatitis C virus (HCV) in chronically and acutely HCV-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

Human immunodeficiency virus: 25 years of diagnostic and therapeutic strategies and their impact on hepatitis B and C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

Prevalence and characteristics of hepatitis B and C virus infections in treatment-naïve HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

Regional spread of HIV-1 M subtype B in middle-aged patients by random env-C2V4 region sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

Epidemiology of human cytomegalovirus (HCMV) in an urban region of Germany: what has changed?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

Oncomodulation by human cytomegalovirus: evidence becomes stronger.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

Oncomodulation by human cytomegalovirus: novel clinical findings open new roads

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

Rapid quantitation of cytomegalovirus DNA in whole blood by a new molecular assay based on automated sample preparation and real-time PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

Diagnostic value of HCMV pp65 antigen detection by FCA for symptomatic and asymptomatic infection: compared to quantification of HCMV DNA and detection of IgM antibody in infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

Pyrosequencing allows the detection of emergent ganciclovir resistance mutations after HCMV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

Measurement of cytotoxic T lymphocyte activity of human cytomegalovirus seropositive individuals by a highly sensitive coupled luminescent method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

Phenotypic and genetic characterization of varicella-zoster virus mutants resistant to acyclovir, brivudine and/or foscarnet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

Screening and identification of host factors interacting with UL14 of herpes simplex virus 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

Monitoring prevalence of varicella-zoster virus clades in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

Novel varicella-zoster virus glycoprotein E gene mutations associated with genotypes A and D

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

Characterisation of the epitope for a herpes simplex virus glycoprotein B-specific monoclonal antibody with high protective capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

Single domain antibodies: promising experimental and therapeutic tools in infection and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

CD28 and IL-4: two heavyweights controlling the balance between immunity and inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

Measles virus-induced immunosuppression: from effectors to mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

Measles virus infection of the CNS: human disease, animal models, and approaches to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

Genome dynamics and its impact on evolution of Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

Resemblance and divergence: the "new" members of the genus Bordetella

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

Virulence determinants involved in differential host niche adaptation of Neisseria meningitidis and Neisseria gonorrhoeae

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

Biofilm formation by the human pathogen Neisseria meningitidis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

Regulation of white-opaque switching in Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

The role of evolutionarily conserved signalling systems in Echinococcus multilocularis development and host-parasite interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

Human immunodeficiency virus type-1 group M quasispecies evolution: diversity and divergence in patients co-infected with active tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

Comparison of performance in two diagnostic methods for tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

A DNA vaccine expressing CFP21 and MPT64 fusion protein enhances BCG-induced protective immunity against Mycobacterium tuberculosis infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

Buruli ulcer disease: prospects for a vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

Prophylactic effect of bacteriophages on mice subjected to chemotherapy-induced immunosuppression and bone marrow transplant upon infection with Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

Induction of immune response to the 17 kDa OMPA Burkholderia cenocepacia polypeptide and protection against pulmonary infection in mice after nasal vaccination with an OMP nanoemulsion-based vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

Humoral immune responses and protective efficacy of sequential B- and T-cell epitopes of V antigen of Yersinia pestis by intranasal immunization in microparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

Mucosal innate response stimulation induced by lipopolysaccharide protects against Bordetella pertussis colonization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

Survival of the fittest: how Brucella strains adapt to their intracellular niche in the host

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

Pro-autophagic signal induction by bacterial pore-forming toxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

The clinical value of neutrophil extracellular traps

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

Analysis of Chlamydia pneumoniae infection in mononuclear cells by reverse transcription-PCR targeted to chlamydial gene transcripts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

Chlamydia pneumoniae infection and Alzheimer's disease: a connection to remember?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

Alzheimer's disease - a neurospirochetosis. Analysis of the evidence following Koch's and Hill's criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

Seroepidemiological study in a Puumala virus outbreak area in South-East Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

Ross River virus infection in a traveller returning from northern Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

No evidence of chikungunya virus and antibodies shortly before the outbreak on Sri Lanka

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

What determines the success or failure of intracellular cutaneous parasites? Lessons learned from leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-011-0219-9

Against the new H1N1 influenza (swine influenza): vaccinate or don't vaccinate (all)? That is currently the question!

21 January 2018

1 reference

12 December 2020

Seroprevalence study in forestry workers of a non-endemic region in eastern Germany reveals infections by Tula and Dobrava-Belgrade hantaviruses.

1 reference

12 December 2020

Characterization of Gag and Nef-specific ELISpot-based CTL responses in HIV-1 infected Indian individuals

1 reference

12 December 2020

Beyond cholesterol: the enigma of atherosclerosis revisited.

1 reference

12 December 2020

Significant increase in travel-associated dengue fever in Germany

1 reference

12 December 2020

Cellular immune response to Mycobacterium tuberculosis-specific antigen culture filtrate protein-10 in south India

1 reference

12 December 2020

Evaluation of a recombinant BCG expressing antigen Ag85B and PPE protein Rv3425 from DNA segment RD11 of Mycobacterium tuberculosis in C57BL/6 mice

1 reference

12 December 2020

10.1007/S00430-011-0219-9

Identifiers

DOI

1 reference

24 August 2017

1 reference